Use of a combination of an aldosterone antagonist and a cyclooxygenase-2 inhibitor in the manufacture of a Medicament for preventing or treating cardiovascular Disorders associated with inflammation

摘要

Use of a combination of Spironolactone and especially epoximexrenona aldosterone antagonists and Inhibitors of the Cycle oxygenase-2 chromene Derivatives, among others, in the manufacture of a Medicament for the treatment of swelling.